Iridex Corp
IRIX- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001006045
In the last 90 days, Iridex Corp insiders filed 4 open-market purchases and 0 sales; 29 institutions reported holding it in 13F filings for Q2 2026, worth $2.47M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Iridex Corp changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 31 | 28 | −3 |
| Shares | 3.70M | 3.89M | +182.0K (+4.9%) |
| Value | $7.56M | $8.43M | +$873.5K (+11.6%) |
New holders (1)
Institutions that held Iridex Corp at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Royal Bank of Canada | 252 | $1.00K | 0.00% |
Sold out (4)
Institutions that held Iridex Corp at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Clayton Partners LLC | 28,793 | $58.5K |
| Susquehanna International Group, LLP | 10,094 | $21.0K |
| Pointe Capital Management LLC | 3,235 | $6.57K |
| UBS Group AG | 2,816 | $5.72K |